Literature DB >> 24257512

Substantial blood pressure reduction with renal denervation in a drug-naïve patient intolerant to antihypertensive pharmacotherapy: a case report.

J Xu1, A Walton2, D Hering1, Y Sata1, M P Schlaich3.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24257512     DOI： 10.1038/jhh.2013.113

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  9 in total

1.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

2.  Management of antihypertensive drugs in three European countries.

Authors:  Federica Nicotra; Björn Wettermark; Miriam C Sturkenboom; Andrea Parodi; Rino Bellocco; Anders Ekbom; Luca Merlino; Andrejs Leimanis; Giuseppe Mancia; Michael Fored; Giovanni Corrao
Journal:  J Hypertens       Date:  2009-09       Impact factor: 4.844

3.  Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice.

Authors:  Thomas A Burke; Miriam C Sturkenboom; Shou-en Lu; Charles E Wentworth; Yong Lin; George G Rhoads
Journal:  J Hypertens       Date:  2006-06       Impact factor: 4.844

4.  Continuation of initial antihypertensive medication after 1 year of therapy.

Authors:  B S Bloom
Journal:  Clin Ther       Date:  1998 Jul-Aug       Impact factor: 3.393

5.  Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.

Authors: 
Journal:  Hypertension       Date:  2011-03-14       Impact factor: 10.190

6.  Resistant hypertension in a tertiary care clinic.

Authors:  M Yakovlevitch; H R Black
Journal:  Arch Intern Med       Date:  1991-09

7.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

8.  Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population.

Authors:  J K Jones; L Gorkin; J F Lian; J A Staffa; A P Fletcher
Journal:  BMJ       Date:  1995-07-29

9.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.